BDAUX | FAFGX | BDAUX / FAFGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 4 years | - |
Gain YTD | 22.917 | 21.910 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 250 | 2,000,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 427M | 290B | 0% |
Annual Yield % from dividends | 0.09 | 0.69 | 13% |
Returns for 1 year | 39.70 | 30.50 | 130% |
Returns for 3 years | 44.13 | 1.64 | 2,684% |
Returns for 5 years | 133.68 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CFJIX | 34.14 | N/A | N/A |
Calvert US Large Cap Value Rspnb Idx I | |||
LAFLX | 13.17 | -0.04 | -0.30% |
Lord Abbett Focused Large Cap Value A | |||
SHSAX | 72.60 | -0.28 | -0.38% |
BlackRock Health Sciences Opps Inv A | |||
AGGIX | 13.10 | -0.05 | -0.38% |
American Century Focused Global Gr I | |||
STSOX | 41.66 | -0.49 | -1.16% |
Sterling Capital SmCp Val C |